AGILENT TECHNOLOGIES, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Agilent Technologies maintained its quarterly dividend at $0.255 per share. The company's stock has seen a 5-day change of 2.28%, a 1st Jan change of 4.66%, and a 12.95% increase overall. This follows a recent downgrade by UBS.
Agilent Technologies (NYSE:A) declared a quarterly dividend of $0.255 per share, payable October 6, 2026, to shareholders of record by October 28, 2026. The company noted future dividends depend on board approval. Agilent reported $6.95B revenue in fiscal 2025.
AGILENT TECHNOLOGIES, INC. (A) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors SANTA CLARA, Calif., Sept. 8, 2026 — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of di
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning A (AGILENT TECHNOLOGIES, INC.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent A coverage spans corporate actions, earnings and technology.
In the last 30 days, A insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($96K). The most active reporter was Dolsten Mikael with 1 filing.
Dividend unchanged; limited price impact.
The dividend may attract income-focused investors, potentially supporting the stock price.
Governance change may influence oversight and strategic direction, but immediate price impact is likely modest.
The upgrade signals improved earnings outlook, likely prompting institutional buying and short-term price appreciation.
Potential revenue uplift from clinical lab adoption and increased market share in digital pathology.
AlphAI scores every news story that mentions A with an AI model for sentiment and relevance, and aggregates insider trades from AGILENT TECHNOLOGIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Agilent Technologies maintained its quarterly dividend at $0.255 per share. The company's stock has seen a 5-day change of 2.28%, a 1st Jan change of 4.66%, and a 12.95% increase overall. This follows a recent downgrade by UBS.
1 min readAgilent Technologies (NYSE:A) declared a quarterly dividend of $0.255 per share, payable October 6, 2026, to shareholders of record by October 28, 2026. The company noted future dividends depend on board approval. Agilent reported $6.95B revenue in fiscal 2025.
1 min readAGILENT TECHNOLOGIES, INC. (A) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors SANTA CLARA, Calif., Sept. 8, 2026 — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of di
2 min readAgilent Technologies (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting an upward trend in earnings estimates. The Zacks rating system, which is based on earnings estimate revisions, suggests a positive outlook for the company's stock price. Analysts have raised their estimates for Agilent by 3.4% over the past three months, with the company expected to earn $6.17 per share for the fiscal year ending October 2026.
2 min readAgilent Technologies (A) launched its FDA-cleared S540MD Slide Scanner System in the U.S., expanding its digital pathology portfolio. The system, designed for high-throughput digitization, can accommodate 540 slides and supports AI-enabled workflows. Agilent aims to streamline diagnostic processes and improve operational efficiency. The stock is down 1.13% in pre-market trading at $148.28.
1 min readAgilent Technologies launched new lab solutions in India, including the 9500 Triple Quadrupole ICP-MS, 8890B and 8860B Gas Chromatography Systems, and OpenLab Sync. These products aim to enhance testing efficiency, compliance, and productivity in pharma, food, and environmental sectors. The company highlighted the role of Indian labs in ensuring quality and safety, with the new technologies designed to improve analytical performance, instrument productivity, and workflow execution. The products
2 min readAgilent (A) acquired Biocare for $950M. The company reported Q3 earnings, with shifts in debt and other financial metrics. The deal expands Agilent's diagnostics portfolio.
1 min readAgilent (A) reported Q3 2026 revenue of $1.88B, up 7.3% and exceeding guidance. EPS was $1.56, up 14% YoY. Strong performance driven by pharma, China growth, and Ignite strategy. Key growth areas include pharma, semiconductors, and AI infrastructure.
2 min readAgilent Technologies (A) reported Q3 2026 sales of $1.88B and net income of $362M, with EPS rising to $1.28. The company raised its full-year revenue and profit guidance, citing strong demand in pharma, China, and advanced materials, plus cost savings from its Ignite program. The updated outlook suggests margin benefits and product launches are offsetting cost pressures. Investors should note ongoing tariff and supply chain risks. Analysts' fair value estimates for Agilent range from $150.54 to
3 min readTD Cowen raised its target price for Agilent Technologies Inc. to $180 from $155. The article also discusses Webull's trading services and risks, including SIPC protection and margin trading details.
1 min read
